Skip to main content

SurgoCap Partners LP

Location
NEW YORK, NY
Portfolio Value
Mid $2,567,711,295
Diversification
Diversified
Filing Date
Global Rank
#1,042 / 8,603 ▼ 144 · as of Mar 2026
Top Industry
Semiconductors 22.0%
3Y Alpha vs SPY
+2.0%
Period ended 3 months ago
Filed May 15, 2026 · 55d
10 quarters · since Dec 2023

Clone Performance

Feb 2024–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+59.3%
SPY
+53.6%
Annualised alpha
+1.8%
Max drawdown
−21.6%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

13 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
18.4%
+7.1 pts
Top 5
67.2%
+13.8 pts
Top 10
93.5%
+10.7 pts
HHI
1,102
Dec 2023 → Mar 2026 · range 807 – 1,154
Diversified+295

Portfolio Trend

10 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Technology 29.9% $767,669,000
Healthcare 28.3% $725,647,986
Financial Services 20.9% $536,030,320
Industrials 18.4% $471,758,529
Unclassified 2.6% $66,605,460

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
5 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
3 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
3 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
6 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
13 positions · $2,567,711,295 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History